Urobilinogen
Probenecid
Alkanes
Rats, Sprague-Dawley
Toxicity Tests
Neurotoxicity Syndromes
Toxicity Tests, Chronic
Isolation and characterization of a urobilinogenoidic chlorophyll catabolite from Hordeum vulgare L. (1/15)
A new type of chlorophyll catabolite was isolated from extracts of de-greened primary leaves of barley (Hordeum vulgare cv. Lambic). Its constitution was elucidated by one-dimensional and two-dimensional [(1)H,(13)C]-homo- and heteronuclear NMR spectroscopic techniques and by high resolution mass spectroscopy. The isolated catabolite, a water-soluble, colorless, and nonfluorescent linear tetrapyrrole, resembles urobilinogen in which one of the propionic side chains forms a five membered isocylic ring system, indicating its origin from the chlorophylls. (+info)Urobilinogen-i is a major derivative of bilirubin in bile of homozygous Gunn rats. (2/15)
Gunn rats lack bilirubin UDP-glycosyltransferases, but diazo-negative derivatives of bilirubin have been described in their bile. In order to investigate this alternative disposal of bilirubin, crude bile samples from Gunn and Wistar rats were directly analysed by h.p.l.c. Besides bilirubin (in Gunn rats) or its glycosides (in Wistar rats), two major compounds were detected. A yellow one corresponded to the previously documented vitamin B-2 and was equally prominent in Gunn rats or Wistar-rat bile. The other compound was colourless, but on standing in contact with air it was spontaneously oxidized to a pinkish-yellow pigment. It was far more prominent in Gunn-rat bile. Analysis of bile obtained after intravenous injection of [14C]bilirubin to Gunn rats demonstrated that this compound was highly labelled. Freezing and thawing of the bile resulted in the formation of a series of diazo-negative derivatives, demonstrating that the original compound was quite labile. Spectral (adsorption and fluorescent) and chromatographic (h.p.l.c., t.l.c. and paper chromatography) analysis of the oxidized form of the labelled compound allowed its identification as urobilin-i. The colourless compound secreted in bile was urobilinogen-i. Administration of neomycin and bacitracin to Gunn rats or gut resection suppressed the biliary excretion of urobilinogen and thus confirmed its intestinal origin. Urobilinogen seems thus to represent the major bilirubin derivative present in Gunn-rat bile. Its breakdown products might represent the so-far-unidentified diazo-negative polar bilirubin derivatives. Since only a small amount of bilirubin is present in Gunn-rat bile, the urobilinogen formed in the intestinal lumen seems to be derived from bilirubin reaching the gut via routes other than the biliary one. (+info)Effectiveness of an outpatient urine screening program. (3/15)
We evaluated the effectiveness of a routine outpatient urinalysis screening program on a sample population of 2600 patients. The 189 abnormal urine results found in 182 patients were followed up by study of any new clinical and laboratory investigations or therapeutic modifications initiated on the basis of any abnormal test result. The urinalysis screening program appeared to have significant bearing on diagnosis or treatment in only 13 patients. Abnormalities found in 150 of the 182 patients were either not noted or no further positive action was taken. Thus we concluded that under the conditions of this study the urine screening program added to hospital costs without significant benefit to the patient. (+info)Abnormal findings on dipstick urinalysis of out-patients with malaria in Abakaliki, Nigeria. (4/15)
BACKGROUND & OBJECTIVES: Malaria, one of the major health challenges of the tropics affecting about 500 million people, particularly the children and pregnant women have been associated with changes in urine compositions. The present study was undertaken to document the urinary abnormalities in malaria patients based on malaria species and the level of malaria parasitaemia. METHODS: Febrile patients (n = 365) with positive Giemsa - stained blood films for malaria recruited from Outpatient Department of Ebonyi State University Teaching Hospital, Abakaliki participated in the study. Patients were classified into two categories (+ and ++) based on parasite density. Apparently healthy individuals (n = 81), without malaria parasite on both thick and thin films of comparable age and gender acted as control group. Urine sample (10 ml) was collected from each participant and analysed using standard laboratory methods and techniques. RESULTS: Seventy - four (20.3%) of the patients had Plasmodium falciparum malaria. Although all the urine parameters were higher in the malarial patients in comparison to the control, only bilirubinuria and urobilinogenuria were statistically significant (p <0.05). Also, bilirubinuria, urobilinogenuria, haematuria and proteinuria were significantly (p < 0.05) higher in P. falciparum infection than in infections with other malaria species, but only in P. falciparum infection, bilirubinuria and urobilinogenuria were significantly (p < 0.05) higher at higher parasitaemia. CONCLUSION: Even though positive blood film for malaria parasite remains the gold standard for the diagnosis of malaria, urinary abnormalities, such as bilirubinuria, urobilinogenuria, proteinuria and haematuria may aid in identifying patients with severe malaria parasitaemia, especially the falciparum malaria. (+info)Reduction of bilirubin ditaurate by the intestinal bacterium Clostridium perfringens. (5/15)
Bilirubin is degraded in the human gut by microflora into urobilinoids. In our study we investigated whether the bilirubin-reducing strain of Clostridium perfringens can reduce bilirubin ditaurate (BDT), a bile pigment of some lower vertebrates, without hydrolysis of the taurine moiety. C. perfringes was incubated under anaerobic conditions with BDT; reduction products were quantified by spectrophotometry and separated by TLC. Based on Rf values of BDT reduction products and synthetic urobilinogen ditaurate, three novel taurine-conjugated urobilinoids were identified. It is likely that bilirubin-reducing enzyme(s) serve for the effective disposal of electrons produced by fermentolytic processes in these anaerobic bacteria. (+info)Liquid-chromatographic assay of urinary porphobilinogen. (6/15)
This is a rapid (10 min per sample), highly sensitive procedure for quantifying urinary porphobilinogen (PBG). Interfering substances are removed by selectively adsorbing PBG onto an ion-exchange resin. After PBG is eluted with 0.5 mol/L formic acid, Ehrlich's reagent is added to produce the chromophore, which is then injected into a liquid chromatograph equipped with a diode-array detector. PBG is separated by a linear gradient (10% to 100%) of methanol in 10 mmol/L phosphate buffer, pH 3.0. Absorbance is monitored at 555 nm. Assay response varies linearly with PBG concentration over the range 0-110 mumol/L (0-25 mg/L). As little as 1.5 mumol/L (0.3 mg/L) can be detected. In prepared urine samples with known PBG concentrations, the within-run coefficient of variation (CV) ranged from 1.7% to 3.2%, the day-to-day CV from 3.5% to 6.1%. PBG concentrations in 24-h urine collected from 25 healthy subjects were all below the detection limit of the assay (less than 1.5 mumol/L). We used the new assay to measure PBG concentrations in the urine of two patients with latent porphyria. This method is more sensitive than spectrophotometric techniques currently used for measuring urinary PBG. (+info)Establishment of a biochemically active intestinal ecosystem in ex-germfree rats. (7/15)
A time course study for the establishment of some biochemical microbial intestinal functions was undertaken in ex-germfree rats conventionalized, i.e., colonized with conventional flora, in three different ways: untreated (group 1); contact with visitor rats (group 2); inoculated with intestinal contents from conventional rats (group 3). The first two groups of rats were inoculated with the intestinal contents from conventional rats after being out of the germfree isolators for 4 weeks. The biochemical parameters studied were degradation of mucin, inactivation of tryptic activity, conversion of cholesterol to coprostanol and of bilirubin to urobilinogen, degradation of beta-aspartylglycine, and formation of short-chain fatty acids. The results showed that the way in which the microbes were introduced and the microbial biochemical functions themselves were of importance. In several cases, social contacts, i.e., contact with visitor rats, were just as effective for the functionally adequate establishment of microbial intestinal functions as was inoculation with intestinal contents from conventional rats. Some of the biochemical parameters studied were established after a few days, whereas the establishment of others was markedly delayed. When inoculated after 4 weeks, all rats in the first two groups were colonized with conventional flora within 1 week. The results indicate that the model system described is suitable when studying buildup mechanisms in intestinal ecosystem(s). (+info)Some aspects of bile acid and urobilinogen excretion and fecal elimination in men given a rural Guatemalan diet and egg formulas with and without added oat bran. (8/15)
Six healthy men were fed a formula diet with and without oat bran and a natural food diet typical of rural Guatemala. No significant difference in dye transit time was found between diets but the Guatemalan diet significantly decreased dye retention time and increased stool frequency. Serum cholesterol and triglyceride levels showed no significant differences among dietary treatments. Excretion of fecal bile acids significantly increased on the Guatemalan and oat bran diets, but fecal bile acid concentration was significantly lower only on the Guatemalan diet. Urinary urobilinogen excretion and fecal urobilinogen concentration were significantly lower with the Guatemalan diet. (+info)Urobilinogen is a yellowish-brown substance that is produced in the liver as a breakdown product of the heme molecule, which is found in red blood cells. It is then excreted in the urine and feces. In the medical field, urobilinogen is often used as a diagnostic tool to evaluate liver function and detect certain types of liver disease. High levels of urobilinogen in the blood or urine can indicate liver damage or dysfunction, while low levels may suggest liver disease or other health problems. Urobilinogen is also used as a component in the testing of urine for the presence of bilirubin, a yellowish-brown pigment that is produced when red blood cells are broken down. Bilirubin is normally excreted in the urine and feces, but when liver function is impaired, it can build up in the blood and cause jaundice, a condition characterized by yellowing of the skin and eyes.
Alkalosis is a medical condition characterized by an increased level of alkaline substances in the blood or other body fluids. This can occur when there is a decrease in the amount of acid in the body, or when there is an increase in the amount of alkaline substances such as bicarbonate ions. There are several types of alkalosis, including respiratory alkalosis, metabolic alkalosis, and mixed alkalosis. Respiratory alkalosis occurs when the body tries to compensate for low levels of carbon dioxide in the blood by breathing more deeply and rapidly, which leads to an increase in the amount of oxygen in the blood and a decrease in the amount of carbon dioxide. Metabolic alkalosis occurs when there is an increase in the production of bicarbonate ions in the body, which can be caused by a variety of factors such as certain medications, kidney disease, or excessive vomiting or diarrhea. Mixed alkalosis occurs when both respiratory and metabolic factors are involved. Symptoms of alkalosis can vary depending on the type and severity of the condition, but may include dizziness, lightheadedness, tingling or numbness in the extremities, muscle cramps, and nausea or vomiting. Treatment for alkalosis typically involves addressing the underlying cause of the condition, such as adjusting breathing patterns or treating the underlying medical condition.
Probenecid is a medication that is used to treat gout and to prevent the formation of kidney stones. It works by blocking the reabsorption of uric acid in the kidneys, which helps to lower the levels of uric acid in the blood. Probenecid is usually taken in combination with allopurinol, another medication that helps to lower uric acid levels. It is available in tablet form and is usually taken two to three times a day. Common side effects of probenecid include nausea, vomiting, and stomach pain. It is important to follow the dosage instructions provided by your healthcare provider and to let them know if you experience any side effects while taking this medication.
In the medical field, alkanes are a group of organic compounds that consist of only carbon and hydrogen atoms. They are the simplest type of hydrocarbon and are often used as solvents, lubricants, and in the production of various medical products. Alkanes are typically classified based on the number of carbon atoms they contain, with the simplest alkane being methane (CH4) and the most complex being undecane (C11H24). Some common alkanes used in medicine include ethane (C2H6), propane (C3H8), butane (C4H10), and pentane (C5H12). Alkanes can be used in a variety of medical applications, including as solvents for medications, as components in medical devices, and as precursors for the production of other medical compounds. However, it is important to note that some alkanes can also be toxic and may cause adverse effects when inhaled or ingested in large quantities.
Methylnitrosourea (MNU) is a chemical compound that is used in research to induce mutations in cells and study the effects of mutagens on DNA. It is a potent carcinogen and has been shown to cause cancer in animals and humans. In the medical field, MNU is used as a tool to study the development of cancer and to identify potential targets for cancer therapy. It is also used in some experimental treatments for certain types of cancer. However, due to its carcinogenic properties, the use of MNU is highly regulated and is typically only performed in controlled laboratory settings.
Neurotoxicity syndromes are a group of disorders that result from exposure to toxic substances that affect the nervous system. These substances can include heavy metals, pesticides, solvents, and other chemicals. Symptoms of neurotoxicity syndromes can vary widely depending on the specific substance and the level of exposure, but may include headaches, dizziness, memory loss, difficulty concentrating, tremors, seizures, and even coma or death in severe cases. Treatment for neurotoxicity syndromes typically involves removing the toxic substance from the body and providing supportive care to manage symptoms. In some cases, medications may be used to help reduce inflammation or prevent further damage to the nervous system.
Chlorpyrifos is an organophosphate insecticide that is commonly used in agriculture to control pests on crops. It is also used in some household and industrial products to kill insects and other pests. In the medical field, chlorpyrifos is not typically used as a treatment for any medical condition. However, exposure to chlorpyrifos can have harmful effects on human health, particularly on the nervous system. Long-term or repeated exposure to chlorpyrifos has been linked to a range of health problems, including developmental delays, learning difficulties, and neurobehavioral disorders. In some cases, exposure to chlorpyrifos can be fatal. It is important to use chlorpyrifos and other pesticides safely and according to the instructions provided by the manufacturer to minimize the risk of exposure.
Urobilinogen
Hemoglobin
Urinalysis
Stercobilin
Jaundice
Stercobilinogen
Bilirubinuria
Para-Dimethylaminobenzaldehyde
Urobilin
Urine test strip
Bilirubin
Ehrlich's reagent
Hyperbilirubinemia in adults
Enterohepatic circulation
Cylindrospermopsin
Neonatal jaundice
Jaffe reaction
Hemolytic jaundice
Dipstick
Heme
List of MeSH codes (D03)
Autoimmune hemolytic anemia
List of MeSH codes (D23)
List of MeSH codes (D04)
Urobilinogen - Wikipedia
Category:Urobilinogen - Wikimedia Commons
Urobilinogen in Urine: MedlinePlus Medical Test
urobilinogen - Baby Birth and Beyond
Urobilinogen: What Makes Our Urine Yellow In Color? » Science ABC
Yellow Fever Workup: Approach Considerations, Specific Tests for Yellow Fever Virus, Liver Function Tests
CFR - Code of Federal Regulations Title 21
Biochemistry (1971-75)
ISO Archives - Randox Laboratories
Compare LabCorp Test Panels - Order LabCorp Blood Tests Online
Registration Dossier - ECHA
Biochemicals | LeeBio.com
32 Biliary Flashcards
Pet Urine Test Strips | Kidney Disease | Home Health UK
Kernicterus: Background, Pathophysiology, Etiology
Metabolites | Free Full-Text | Obesity-Related Metabolome and Gut Microbiota Profiles of Juvenile Göttingen Minipigs-Long-Term...
NIOSHTIC-2 Search Results - Full View
Stool Tests: Normal Values - Resources - MSD Manual Professional Edition
Other
Biochemistry Analyzers,Blood Gas Analyzers Suppliers & Manufacturers
Registration Dossier - ECHA
Porphyrins, Blood and Urine | Davis's Lab & Diagnostic Tests
Fever Screening | 46 Tests @ Rs.999
Vet 9™ Urine Tests | Sensor Health Sciences
Bilirubin5
- Urobilinogen comes from bilirubin. (medlineplus.gov)
- Good bacteria in your intestines breaks down the bilirubin in your bile and makes urobilinogen. (medlineplus.gov)
- The coloring agent of urine is known as urobilinogen, which gives it the distinct yellow hue and is produced by the breakdown of bilirubin. (scienceabc.com)
- Some of this bilirubin also escapes into the blood, forming urobilinogen , which is excreted through our urine. (scienceabc.com)
- Bilirubin reduction in the gut leads to a product called urobilinogen, which is excreted in urine. (medicregister.com)
Urine13
- What is a Urobilinogen in Urine Test? (medlineplus.gov)
- A urobilinogen in urine test measures the amount of urobilinogen in your urine (pee). (medlineplus.gov)
- Normal urine contains some urobilinogen. (medlineplus.gov)
- Too much urobilinogen in urine may be a sign of a liver disease , such as hepatitis or cirrhosis , or certain types of anemia . (medlineplus.gov)
- A small amount of urobilinogen leaves your body in urine. (medlineplus.gov)
- Little or no urobilinogen in urine may mean that something is blocking bile from flowing into your intestines. (medlineplus.gov)
- A urobilinogen in urine test may part of a urinalysis , a test that measures different cells, chemicals, and other substances in your urine. (medlineplus.gov)
- Why do I need a urobilinogen in urine test? (medlineplus.gov)
- Urobilinogen: What Makes Our Urine Yellow In Color? (scienceabc.com)
- During the filtration and reabsorption process, our kidneys filter out this urobilinogen (or urochrome ) from the blood and secrete it via our urine. (scienceabc.com)
- It is this urobilinogen that colors urine with its distinctly yellowish hue. (scienceabc.com)
- A urinary urobilinogen (nonquantitative) test system is a device intended to detect and estimate urobilinogen (a bile pigment degradation product of red cell hemoglobin) in urine. (fda.gov)
- and urobilinogen both urine and stool. (medscape.com)
Bile2
- Little or no urobilinogen may be a sign of other problems with your liver, gallbladder , or bile ducts . (medlineplus.gov)
- Your liver can't recycle urobilinogen into bile because of liver disease. (medlineplus.gov)
Stool1
- Some of the urobilinogen leaves your body in your stool (poop). (medlineplus.gov)
Detect1
- The strips also detect Urobilinogen, Nitrites and Leukocytes. (homehealth-uk.com)
Test1
- Sec. 862.1785 Urinary urobilinogen (nonquantitative) test system. (fda.gov)
Bilirubin reduction to urobilinogen1
- We dedicate significant efforts to investigating enzymes involved in bilirubin reduction to urobilinogen, a critical process for maintaining balanced bilirubin levels in the body. (nih.gov)
Urinalysis1
- Urinalysis demonstrated a slightly elevated urobilinogen. (cdc.gov)
Fecal1
- in some cases, mild bilirubinemia, changes in osmotic fragility, increase in lactic dehydrogenase and fecal urobilinogen, and occasionally some neurological abnormalities are found. (nih.gov)
Liver disease1
- Urobilinogen: Checks for liver disease. (homecareneeds.com.sg)
Products1
- However, the hypothesized bacterial enzyme that reduces bilirubin to urobilinogen, a key step that produces the excretable waste products of this pathway, has remained unidentified. (nih.gov)